|

ADC THERAPEUTICS SA (ADCT)

CH0499880968 - Common Stock

1.02  -0.05 (-4.67%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to ADCT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.16. This target is 700% above the current price.
ADCT was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ADCT.
In the previous month the buy percentage consensus was at a similar level.
ADCT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.023.036.128.1617.85 - 197.06% 500.00% 700.00% 1,650.00%
Up and Down Grades
Date Firm Action Rating
2023-11-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-09 TD Cowen Downgrade Outperform -> Market Perform
2023-11-08 RBC Capital Maintains Outperform -> Outperform
2023-09-19 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-12 RBC Capital Maintains Outperform -> Outperform
2023-08-10 JP Morgan Upgrade Underweight -> Neutral
2023-08-09 RBC Capital Maintains Outperform -> Outperform
2023-07-25 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-11 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-06-20 HC Wainwright & Co. Maintains Buy -> Buy
2023-05-10 RBC Capital Maintains Outperform
2023-04-24 B of A Securities Downgrade Neutral -> Underperform
2023-02-13 RBC Capital Maintains Outperform
2023-01-24 Morgan Stanley Maintains Equal-Weight
2023-01-04 HC Wainwright & Co. Maintains Buy
2022-11-14 Morgan Stanley Maintains Equal-Weight
2022-11-09 RBC Capital Maintains Outperform
2022-11-09 B of A Securities Downgrade Buy -> Neutral
2022-09-21 JP Morgan Initiate Overweight
2022-09-19 HC Wainwright & Co. Maintains Buy
2022-09-09 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-08-22 HC Wainwright & Co. Maintains Buy
2022-08-10 RBC Capital Maintains Outperform
2022-07-11 HC Wainwright & Co. Maintains Buy
2022-05-10 RBC Capital Maintains Outperform
2022-05-10 Morgan Stanley Maintains Overweight
2022-04-12 Morgan Stanley Maintains Overweight
2022-03-04 HC Wainwright & Co. Maintains Buy
2022-02-01 Morgan Stanley Maintains Overweight
2021-11-09 Wolfe Research Initiate Outperform